Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Cummins

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Health Technology Assessment (Winchester, England)|June 4, 2019
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCTNicholas Ja Webb, Rebecca L Woolley, Tosin Lambe, et al.
Health Technology Assessment (Winchester, England)|April 10, 2025
Stopping anticoagulation for isolated or incidental subsegmental pulmonary embolism: the challenges and lessons from the STOPAPE RCTDaniel Lasserson, Pooja Gaddu, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)|July 6, 2024
Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocolDaniel Lasserson, Pooja Gaddu, Samir Mehta, et al.
BMJ (Clinical Research Ed.)|July 24, 2019
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluationNicholas J A Webb, Rebecca L Woolley, Tosin Lambe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 18, 2013
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohortYael Hacohen, Michael Absoud, Mark Woodhall, et al.
BMC Pediatrics|July 30, 2011
Paediatric UK demyelinating disease longitudinal study (PUDDLS)Michael Absoud, Carole Cummins, Wui K Chong, et al.
Cancers|September 23, 2022
Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK StudyCarole Cummins, Satyam Kumar, Joanna Long, et al.
Cancers|January 11, 2024
Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer-Quality of Life Evaluation Research) Prospective, International, Multicentre StudyAarti Lakhiani, Carole Cummins, Satyam Kumar, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 5, 2021
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort studySudha Sundar, Carole Cummins, Satyam Kumar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2012
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging featuresMichael Absoud, Ming J Lim, Wui K Chong, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Health Technology Assessment (Winchester, England)|June 4, 2019
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCTNicholas Ja Webb, Rebecca L Woolley, Tosin Lambe, et al.
Health Technology Assessment (Winchester, England)|April 10, 2025
Stopping anticoagulation for isolated or incidental subsegmental pulmonary embolism: the challenges and lessons from the STOPAPE RCTDaniel Lasserson, Pooja Gaddu, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)|July 6, 2024
Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocolDaniel Lasserson, Pooja Gaddu, Samir Mehta, et al.
BMJ (Clinical Research Ed.)|July 24, 2019
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluationNicholas J A Webb, Rebecca L Woolley, Tosin Lambe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 18, 2013
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohortYael Hacohen, Michael Absoud, Mark Woodhall, et al.
BMC Pediatrics|July 30, 2011
Paediatric UK demyelinating disease longitudinal study (PUDDLS)Michael Absoud, Carole Cummins, Wui K Chong, et al.
Cancers|September 23, 2022
Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK StudyCarole Cummins, Satyam Kumar, Joanna Long, et al.
Cancers|January 11, 2024
Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer-Quality of Life Evaluation Research) Prospective, International, Multicentre StudyAarti Lakhiani, Carole Cummins, Satyam Kumar, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 5, 2021
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort studySudha Sundar, Carole Cummins, Satyam Kumar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2012
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging featuresMichael Absoud, Ming J Lim, Wui K Chong, et al.
Pageof 7